Fluticasone Propionate Protects against Ozone-Induced Airway Inflammation and Modified Immune Cell Activation Markers in Healthy Volunteers
Open Access
- 1 June 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Environmental Health Perspectives
- Vol. 116 (6) , 799-805
Abstract
Background: Ozone exposure induces airway neutrophilia and modifies innate immune monocytic cell-surface phenotypes in healthy individuals. High-dose inhaled corticosteroids can reduce O3-induced airway inflammation, but their effect on innate immune activation is unknown. Objectives: We used a human O3 inhalation challenge model to examine the effectiveness of clinically relevant doses of inhaled corticosteroids on airway inflammation and markers of innate immune activation in healthy volunteers. Methods: Seventeen O3-responsive subjects [> 10% increase in the percentage of polymorphonuclear leukocytes (PMNs) in sputum, PMNs per milligram vs. baseline sputum] received placebo, or either a single therapeutic dose (0.5 mg) or a high dose (2 mg) of inhaled fluticasone proprionate (FP) 1 hr before a 3-hr O3 challenge (0.25 ppm) on three separate occasions at least 2 weeks apart. Lung function, exhaled nitric oxide, sputum, and systemic biomarkers were assessed 1–5 hr after the O3 challenge. To determine the effect of FP on cellular function, we assessed sputum cells from seven subjects by flow cytometry for cell-surface marker activation. Results: FP had no effect on O3-induced lung function decline. Compared with placebo, 0.5 mg and 2 mg FP reduced O3-induced sputum neutrophilia by 18% and 35%, respectively. A similar effect was observed on the airway-specific serum biomarker Clara cell protein 16 (CCP16). Furthermore, FP pretreatment significantly reduced O3-induced modification of CD11b, mCD14, CD64, CD16, HLA-DR, and CD86 on sputum monocytes in a dose-dependent manner. Conclusions: This study confirmed and extended data demonstrating the protective effect of FP against O3-induced airway inflammation and immune cell activation.Keywords
This publication has 36 references indexed in Scilit:
- A critical review of the use of Clara cell secretory protein (CC16) as a biomarker of acute or chronic pulmonary effectsBiomarkers, 2007
- Role and regulation of lung collectins in allergic airway sensitizationPharmacology & Therapeutics, 2006
- Inhaled LPS induces blood release of Clara cell specific protein (CC16) in human beingsJournal of Allergy and Clinical Immunology, 2005
- Health effects of air pollutionJournal of Allergy and Clinical Immunology, 2004
- Similarities and Differences in Asthma and Chronic Obstructive Pulmonary Disease ExacerbationsProceedings of the American Thoracic Society, 2004
- Circulating CD11b expression correlates with the neutrophil response and airway mCD14 expression is enhanced following ozone exposure in humansClinical Immunology, 2004
- Ozone exposure enhances antigen-presenting activity of interstitial lung cells in ratsToxicology, 2004
- IL-4 induces production of the lung collectin surfactant protein-DJournal of Allergy and Clinical Immunology, 2004
- Blunting airway eosinophilic inflammation results in a decreased airway neutrophil response to inhaled LPS in patients with atopic asthma: A role for CD14Journal of Allergy and Clinical Immunology, 2001
- Sputum Phagocytes from Healthy Individuals Are Functional and Activated: A Flow Cytometric Comparison with Cells in Bronchoalveolar Lavage and Peripheral BloodClinical Immunology, 2000